September 2015

A <797> Rewritten with Patient Safety in Mind

Revised USP Standards for Compounding Sterile Preparations

Gigi Davidson, R.Ph., DICVP, Chair of USP's Compounding Expert Committee shares her thoughts and background information on proposed revisions to <797> Pharmaceutical Compounding—Sterile Preparations. Compounding practitioners are encouraged to view and share comments on the changes online.

Share

Updating Quality Standards for Nuclear Medicine and Radioactive Materials

Revised USP Quality Standards for Radioactive Articles

Nuclear medicine and medical imaging, such as PET scans, have changed how many diseases (e.g., cancer, Alzheimer's) are evaluated and treated. Learn how USP is updating its standards to reflect “state-of-the-industry” practices in this field. 

Share

USP and Synthetic Therapeutic Peptides

USP and SyntheticTherapeutic Peptides

Anita Szajek, Ph.D., principal scientific liaison to USP’s Expert Panel on Therapeutic Peptides, examines therapeutic peptides, the transition from recombinant to synthetic manufacturing routes, and regulatory and quality-related questions.

Share

How to Get Involved with USP

Get Involved with USP

If you are interested in USP’s activities and want to apply your scientific expertise to improving global public health, here are some ways to get involved.

Share